Suppr超能文献

意大利南部乳糜泻患者中HLA-DQ7单倍型的高频率:对5535名乳糜泻风险受试者的回顾性评估。

High Frequency of Haplotype HLA-DQ7 in Celiac Disease Patients from South Italy: Retrospective Evaluation of 5,535 Subjects at Risk of Celiac Disease.

作者信息

Tinto Nadia, Cola Arturo, Piscopo Chiara, Capuano Marina, Galatola Martina, Greco Luigi, Sacchetti Lucia

机构信息

Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy; CEINGE-Advanced Biotechnology, s. c. a r. l., Naples, Italy.

Department of Molecular Medicine and Medical Biotechnology, University of Naples "Federico II", Naples, Italy; Department of Translational Medical Sciences, Section of Pediatrics, University of Naples "Federico II", Naples, Italy.

出版信息

PLoS One. 2015 Sep 23;10(9):e0138324. doi: 10.1371/journal.pone.0138324. eCollection 2015.

Abstract

BACKGROUND

Celiac disease (CD) has a strong genetic component mainly due to HLA DQ2/DQ8 encoding genes. However, a minority of CD patients are DQ2/DQ8-negative. To address this issue, we retrospectively characterized HLA haplotypes in 5,535 subjects at risk of CD (either relatives of CD patients or subjects with CD-like symptoms) referred to our center during a 10-year period.

METHODS

We identified loci DQA1/DQB1/DRB1 by sequence-specific oligonucleotide-PCR and sequence-specific primer-PCR; anti-transglutaminase IgA/IgG and anti-endomysium IgA by ELISA and indirect immunofluorescence, respectively.

RESULTS

We diagnosed CD in 666/5,535 individuals, 4.2% of whom were DQ2/DQ8-negative. Interestingly, DQ7 was one of the most abundant haplotypes in all CD patients and significantly more frequent in DQ2/DQ8-negative (38%) than in DQ2/DQ8-positive CD patients (24%) (p<0.05).

CONCLUSION

Our data lend support to the concept that DQ7 represents an additive or independent CD risk haplotype with respect to DQ2/DQ8 haplotypes but this finding should be verified in other large CD populations.

摘要

背景

乳糜泻(CD)具有很强的遗传因素,主要归因于编码HLA DQ2/DQ8的基因。然而,少数CD患者为DQ2/DQ8阴性。为解决这一问题,我们回顾性分析了10年间转诊至本中心的5535名有CD风险的受试者(CD患者的亲属或有CD样症状的受试者)的HLA单倍型。

方法

我们通过序列特异性寡核苷酸PCR和序列特异性引物PCR鉴定DQA1/DQB1/DRB1位点;分别通过酶联免疫吸附测定法(ELISA)和间接免疫荧光法检测抗转谷氨酰胺酶IgA/IgG和抗肌内膜IgA。

结果

我们在5535名个体中诊断出666例CD,其中4.2%为DQ2/DQ8阴性。有趣的是,DQ7是所有CD患者中最常见的单倍型之一,在DQ2/DQ8阴性的CD患者中(38%)比在DQ2/DQ8阳性的CD患者中(24%)更为常见(p<0.05)。

结论

我们的数据支持以下观点,即相对于DQ2/DQ8单倍型,DQ7代表一种附加的或独立的CD风险单倍型,但这一发现应在其他大型CD人群中得到验证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/db60/4580462/aeb33ed05323/pone.0138324.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验